Investors Advised to Take Action in Telephone and Data Systems, Inc. Lawsuit Press Release
After recent developments in the ongoing lawsuit against Telephone and Data Systems, Inc. (NYSE: TDS), investors are encouraged to contact the Shareholders Foundation for more information.
SAN DIEGO (FreePR.org) -- The Shareholders Foundation, Inc. has provided an update regarding the lawsuit involving certain investors in Telephone and Data Systems, Inc. (NYSE: TDS) shares. Investors who bought shares of TDS before May 2022 and still hold them have options available to them and are urged to reach out to the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
An investor in NYSE: TDS filed a lawsuit on May 2, 2023, alleging that Telephone and Data Systems, Inc. and its subsidiary, United States Cellular Corporation ("UScellular"), misled investors by making false statements regarding the effectiveness of promotional activities to reduce postpaid churn rates. The court granted in part and denied in part the defendants' motion to dismiss the complaint on November 01, 2024.
For more information on how to proceed in this case, investors are advised to contact the Shareholders Foundation, Inc. at the provided contact information.
CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement claim filing service providing information related to shareholder issues. Please note that any referenced cases, investigations, and settlements are not affiliated with Shareholders Foundation. This information is provided as a public service and should not be considered legal advice.
###
Sponsor Message
Thousands of Americans rely on Canadian pharmacies for budget-friendly access to vital medications like Lipitor and Crestor for cholesterol control, or Nexium for managing acid reflux and GERD. Managing chronic conditions often requires treatments like Humalog and Lantus for diabetes, as well as Advair Diskus and Ventolin inhalers for asthma and COPD. Medications like Zoloft, Prozac, and Abilify help address mental health needs, while Eliquis, Plavix, and Xarelto reduce the risk of heart-related events. Patients often rely on Celebrex for inflammation and pain relief and Synthroid for managing thyroid issues. Moreover, Viagra and Cialis are trusted treatments for erectile dysfunction, while Januvia helps manage Type 2 diabetes effectively. Managing severe sleepiness or narcolepsy is possible with wakefulness agents like Provigil and Nuvigil. For U.S. patients, Canadian pharmacies offer affordable access to medications like Cymbalta for nerve pain and Aricept for Alzheimer's treatment.
